Waterfront Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Waterfront Wealth's ABBV Position: Q2 2026 in Review
Waterfront Wealth increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $38.1K and bringing the position to 10,643 shares worth $2.64M. The position accounts for 0.41% of the portfolio, ranked #76.
Waterfront Wealth first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Waterfront Wealth held 10,643 shares of AbbVie worth $2.64M as of Q2 2026.
- Waterfront Wealth bought 177 AbbVie shares in Q2 2026, an estimated $38.1K.
- AbbVie made up 0.41% of Waterfront Wealth's portfolio in Q2 2026, its #76 holding.
- Waterfront Wealth first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.